• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dosimetric accuracy of planning and delivering small proton therapy fields.计划和实施小质子治疗野的剂量学准确性。
Phys Med Biol. 2010 Dec 21;55(24):7425-38. doi: 10.1088/0031-9155/55/24/003. Epub 2010 Nov 19.
2
An algorithm to assess the need for clinical Monte Carlo dose calculation for small proton therapy fields based on quantification of tissue heterogeneity.一种基于组织不均匀性量化的小型质子治疗场临床蒙特卡罗剂量计算需求评估算法。
Med Phys. 2013 Aug;40(8):081704. doi: 10.1118/1.4812682.
3
Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.评估蒙特卡罗算法在接受立体定向体部放射治疗的周围型肺癌患者中符合 RTOG 0915 剂量学标准的应用。
J Appl Clin Med Phys. 2016 May 8;17(3):277-293. doi: 10.1120/jacmp.v17i3.6077.
4
Quantifying the effect of air gap, depth, and range shifter thickness on TPS dosimetric accuracy in superficial PBS proton therapy.量化气隙、深度和射程移位器厚度对浅表质子束扫描质子治疗中治疗计划系统剂量学准确性的影响。
J Appl Clin Med Phys. 2018 Jan;19(1):164-173. doi: 10.1002/acm2.12241. Epub 2017 Dec 14.
5
Evaluation of GATE-RTion (GATE/Geant4) Monte Carlo simulation settings for proton pencil beam scanning quality assurance.用于质子笔形束扫描质量保证的GATE-RTion(GATE/Geant4)蒙特卡罗模拟设置评估。
Med Phys. 2020 Nov;47(11):5817-5828. doi: 10.1002/mp.14481. Epub 2020 Oct 17.
6
A benchmarking method to evaluate the accuracy of a commercial proton monte carlo pencil beam scanning treatment planning system.一种用于评估商用质子蒙特卡罗笔形束扫描治疗计划系统准确性的基准测试方法。
J Appl Clin Med Phys. 2017 Mar;18(2):44-49. doi: 10.1002/acm2.12043. Epub 2017 Feb 2.
7
Clinical implementation of full Monte Carlo dose calculation in proton beam therapy.质子束治疗中全蒙特卡罗剂量计算的临床应用
Phys Med Biol. 2008 Sep 7;53(17):4825-53. doi: 10.1088/0031-9155/53/17/023. Epub 2008 Aug 13.
8
Limitations of analytical dose calculations for small field proton radiosurgery.小视野质子放射外科分析剂量计算的局限性
Phys Med Biol. 2017 Jan 7;62(1):246-257. doi: 10.1088/1361-6560/62/1/246. Epub 2016 Dec 17.
9
Commissioning of pencil beam and Monte Carlo dose engines for non-isocentric treatments in scanned proton beam therapy.在扫描质子束治疗中为非等中心治疗启用笔形束和蒙特卡罗剂量引擎。
Phys Med Biol. 2019 Aug 28;64(17):17NT01. doi: 10.1088/1361-6560/ab3557.
10
Benchmarking a GATE/Geant4 Monte Carlo model for proton beams in magnetic fields.在磁场中对质子束进行 GATE/Geant4 蒙特卡罗模型的基准测试。
Med Phys. 2020 Jan;47(1):223-233. doi: 10.1002/mp.13883. Epub 2019 Nov 13.

引用本文的文献

1
Proton Therapy for Uveal Melanoma on a Pencil Beam Scanning Gantry.笔形束扫描机架上的质子治疗用于葡萄膜黑色素瘤
Adv Radiat Oncol. 2025 Jul 14;10(8):101782. doi: 10.1016/j.adro.2025.101782. eCollection 2025 Aug.
2
Gantry-based pencil beam scanning proton therapy for uveal melanoma: IMPT versus proton arc therapy.基于龙门架的笔形束扫描质子治疗葡萄膜黑色素瘤:调强质子治疗与质子弧形治疗对比
Radiat Oncol. 2025 Apr 2;20(1):48. doi: 10.1186/s13014-025-02621-y.
3
Secondary particle production and physical properties during dose enhancement for spread-out Bragg peaks.扩展布拉格峰剂量增强过程中的次级粒子产生及物理特性
Transl Cancer Res. 2019 Aug;8(4):1449-1456. doi: 10.21037/tcr.2019.07.54.
4
Evaluation of the dosimetric effect of scattered protons in clinical practice in passive scattering proton therapy.评估被动散射质子治疗中散射质子的临床剂量学效应。
J Appl Clin Med Phys. 2021 Jun;22(6):104-118. doi: 10.1002/acm2.13284. Epub 2021 May 25.
5
Anteriorly Oriented Beam Arrangements with Daily in Vivo Range Verification for Proton Therapy of Prostate Cancer: Rectal Toxicity Rates.用于前列腺癌质子治疗的具有每日体内范围验证的前向射束排列:直肠毒性率
Int J Part Ther. 2016 Mar;2(4):509-517. doi: 10.14338/IJPT-15-00015.1. Epub 2016 Mar 24.
6
Is an analytical dose engine sufficient for intensity modulated proton therapy in lung cancer?用于肺癌调强质子治疗的分析剂量引擎是否足够?
Br J Radiol. 2020 Mar;93(1107):20190583. doi: 10.1259/bjr.20190583. Epub 2019 Nov 20.
7
Experimental Assessment of Proton Dose Calculation Accuracy in Small-Field Delivery Using a Mevion S250 Proton Therapy System.使用Mevion S250质子治疗系统对小射野照射中质子剂量计算准确性的实验评估
J Med Phys. 2018 Oct-Dec;43(4):221-229. doi: 10.4103/jmp.JMP_33_18.
8
Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents.用于成像和治疗剂临床前研究的小鼠特异性体内剂量测定法。
Health Phys. 2018 Apr;114(4):450-459. doi: 10.1097/HP.0000000000000789.
9
Assessing the Clinical Impact of Approximations in Analytical Dose Calculations for Proton Therapy.评估质子治疗分析剂量计算中近似值的临床影响。
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1157-1164. doi: 10.1016/j.ijrobp.2015.04.006. Epub 2015 Apr 8.
10
The physics of proton therapy.质子治疗的物理学原理。
Phys Med Biol. 2015 Apr 21;60(8):R155-209. doi: 10.1088/0031-9155/60/8/R155. Epub 2015 Mar 24.

本文引用的文献

1
Field size dependence of the output factor in passively scattered proton therapy: influence of range, modulation, air gap, and machine settings.被动散射质子治疗中输出因子的射野大小依赖性:射程、调制、气隙和机器设置的影响
Med Phys. 2009 Jul;36(7):3205-10. doi: 10.1118/1.3152111.
2
Commissioning a passive-scattering proton therapy nozzle for accurate SOBP delivery.调试用于精确递送扩展布拉格峰的被动散射质子治疗喷嘴。
Med Phys. 2009 Jun;36(6):2172-80. doi: 10.1118/1.3121489.
3
Dose to water versus dose to medium in proton beam therapy.质子束治疗中水体剂量与介质剂量对比
Phys Med Biol. 2009 Jul 21;54(14):4399-421. doi: 10.1088/0031-9155/54/14/004. Epub 2009 Jun 23.
4
Clinical implementation of full Monte Carlo dose calculation in proton beam therapy.质子束治疗中全蒙特卡罗剂量计算的临床应用
Phys Med Biol. 2008 Sep 7;53(17):4825-53. doi: 10.1088/0031-9155/53/17/023. Epub 2008 Aug 13.
5
Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.使用被动散射法产生的质子治疗束准直器散射的蒙特卡罗研究。
Phys Med Biol. 2008 Jan 21;53(2):487-504. doi: 10.1088/0031-9155/53/2/014. Epub 2007 Dec 28.
6
Determination of output factors for small proton therapy fields.小质子治疗射野输出因子的测定
Med Phys. 2007 Feb;34(2):489-98. doi: 10.1118/1.2428406.
7
The prediction of output factors for spread-out proton Bragg peak fields in clinical practice.临床实践中扩展质子布拉格峰射野输出因子的预测
Phys Med Biol. 2005 Dec 21;50(24):5847-56. doi: 10.1088/0031-9155/50/24/006. Epub 2005 Dec 6.
8
Adaptation of GEANT4 to Monte Carlo dose calculations based on CT data.将GEANT4应用于基于CT数据的蒙特卡罗剂量计算。
Med Phys. 2004 Oct;31(10):2811-8. doi: 10.1118/1.1796952.
9
Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility.用于质子放射治疗设备的喷嘴设计、调试和质量保证的精确蒙特卡罗模拟。
Med Phys. 2004 Jul;31(7):2107-18. doi: 10.1118/1.1762792.
10
Monitor unit calculations for range-modulated spread-out Bragg peak fields.射程调制扩展布拉格峰场的监测单元计算
Phys Med Biol. 2003 Sep 7;48(17):2797-808. doi: 10.1088/0031-9155/48/17/305.

计划和实施小质子治疗野的剂量学准确性。

Dosimetric accuracy of planning and delivering small proton therapy fields.

机构信息

Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

出版信息

Phys Med Biol. 2010 Dec 21;55(24):7425-38. doi: 10.1088/0031-9155/55/24/003. Epub 2010 Nov 19.

DOI:10.1088/0031-9155/55/24/003
PMID:21098920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3376899/
Abstract

A detailed Monte Carlo model of a proton therapy treatment head was commissioned to simulate the delivery of small field proton treatments. Small fields are challenging in the planning and quality assurance process because of aperture scattering and dosimetric disequilibrium. Four patients with small fields used in all or parts of their treatment course were studied, including two stereotactic patients and two fractionated patients. For the two stereotactic patients the overall difference of the dose covering at least 95% of the gross tumor volume between the Monte Carlo calculations and the delivery was -0.2% and -1.6%, respectively. For the two fractionated patients the overall difference of the dose covering at least 95% of the clinical target volume was -3.0% and 1.0%, respectively. We have thus confirmed that our current planning and delivery process for small proton fields is accurate enough to treat small lesions in the patient. Furthermore, we studied the impact of field size corrections and identified limitations of the pencil beam algorithm for predicting hot and cold spots and range degradation in the target due scattering in heterogeneities. For the four cases studied in this paper, these limitations appear to impact individual field calculations, but do not have a significant impact on the prescribed dose over multiple fields.

摘要

委托制作了一个质子治疗头的详细蒙特卡罗模型,以模拟小射野质子治疗的实施。由于孔径散射和剂量失衡,小射野在规划和质量保证过程中极具挑战性。研究了 4 名患者的小射野治疗,他们全部或部分采用了小射野治疗,包括 2 名立体定向患者和 2 名分次治疗患者。对于 2 名立体定向患者,蒙特卡罗计算和实施的至少 95%肿瘤体积覆盖的剂量总体差异分别为-0.2%和-1.6%。对于 2 名分次治疗患者,至少 95%临床靶体积覆盖的剂量总体差异分别为-3.0%和 1.0%。因此,我们确认目前用于小质子野的计划和实施过程足以治疗患者的小病变。此外,我们研究了射野大小校正的影响,并确定了铅笔束算法在预测由于散射引起的热点和冷点以及目标内射程退化方面的局限性。对于本文研究的 4 个病例,这些局限性似乎会影响单个射野的计算,但不会对多个射野的规定剂量产生显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/120c37e06953/nihms-375494-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/cf60f92e56d2/nihms-375494-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/44fa69f78a48/nihms-375494-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/2a0880454e82/nihms-375494-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/e76fea2f99a8/nihms-375494-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/665574df8176/nihms-375494-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/e4116266b5bd/nihms-375494-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/61afa755531b/nihms-375494-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/120c37e06953/nihms-375494-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/cf60f92e56d2/nihms-375494-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/44fa69f78a48/nihms-375494-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/2a0880454e82/nihms-375494-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/e76fea2f99a8/nihms-375494-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/665574df8176/nihms-375494-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/e4116266b5bd/nihms-375494-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/61afa755531b/nihms-375494-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1da3/3376899/120c37e06953/nihms-375494-f0008.jpg